Galaxy银河|澳门官网·登录入口

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

TORC1 controls G1-S cell cycle transition in yeast via Mpk1 and the greatwall kinase pathway.

Nat Commun. 2015; 
Moreno-TorresMarta,JaquenoudMalika,De VirgilioCla
Products/Services Used Details Operation
Catalog Antibody Anti-Sic1, (sc-50441; Santa Cruz), anti-c-Myc (9E10; sc-40; Santa Cruz), anti-Adh1 (Calbiochem), phospho-specific anti-Sic1-pThr173 (produced by GenScript)…. Get A Quote

摘要

The target of rapamycin complex 1 (TORC1) pathway couples nutrient, energy and hormonal signals with eukaryotic cell growth and division. In yeast, TORC1 coordinates growth with G1-S cell cycle progression, also coined as START, by favouring the expression of G1 cyclins that activate cyclin-dependent protein kinases (CDKs) and by destabilizing the CDK inhibitor Sic1. Following TORC1 downregulation by rapamycin treatment or nutrient limitation, clearance of G1 cyclins and C-terminal phosphorylation of Sic1 by unknown protein kinases are both required for Sic1 to escape ubiquitin-dependent proteolysis prompted by its flagging via the SCF(Cdc4) (Skp1/Cul1/F-box protein) ubiquitin ligase complex. Here we ... More

关键词

XML 地图